Amyloid-beta PET and CSF in an autopsy-confirmed cohortReimand, Juhan; Boon, Baayla D.C.; Collij, Lyduine E.; Teunissen, Charlotte E.; Rozemuller, Annemieke J.M.; Van Berckel, Bart N.M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeAnnals of clinical and translational neurology2020 / p. 2150−2160 https://doi.org/10.1002/acn3.51195 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

Discordant amyloid-β PET and CSF biomarkers and its clinical consequencesWilde, Arno de; Reimand, Juhan; Teunissen, Charlotte E.; Zwan, MarissaAlzheimer's Research & Therapy2019 / art. 78, 13 p. : ill https://doi.org/10.1186/s13195-019-0532-x Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

PET and CSF amyloid-β status are differently predicted by patient features: Information from discordant casesReimand, Juhan; Wilde, Arno de; Teunissen, Charlotte E.; Zwan, MarissaAlzheimer's Research & Therapy2019 / art. 100, 16 p. : ill https://doi.org/10.1186/s13195-019-0561-5 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

Why is amyloid-β PET requested after performing CSF biomarkers?Reimand, Juhan; Groot, Colin; Teunissen, Charlotte E.; Windhorst, Albert D.; Boellaard, Ronald; Barkhof, Frederike; Nazarenko, Sergei; van der Flier, Wiesje M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeJournal of Alzheimer's disease2020 / p. 559-569 https://doi.org/10.3233/JAD-190836 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS